Skip to main content

Table 1 Experimental details

From: (Z)-N-(3-([1,1'-biphenyl]-2-yl)-4-heptyl-4-hydroxythiazolidin-2-ylidene)-4-bromobenzamide as carbonic anhydrase inhibitor: exploration of its in vitro and in silico studies

Crystal data

 Chemical formula

C29H31BrN2O2S

 Mr

551.53

 Crystal system

Triclinic

 Space group

P -1

 Temperature (K)

173

 abc (Å)

8.9718 (4), 12.3073 (7), 12.9424 (7)

 α, β, γ (°)

79.777 (5), 77.715 (4), 73.213 (5)

 V (Å3)

1326.52 (13)

 Z

2

 Radiation type

Cu Kα

 µ (mm−1)

3.07

 Crystal size (mm)

0.46 × 0.38 × 0.28

Data collection

 Diffractometer

Rigaku Oxford Diffraction Eos Gemini

 Absorption correction

Multi-scan

CrysAlis PRO 1.171.38.46 [26] Empirical absorption correction using spherical harmonics, implemented in SCALE3 ABSPACK scaling algorithm

 TminTmax

0.808, 1.000

 No. of measured, independent and observed [I > 2σ(I)] reflections

8811, 5010, 4676

 Rint

0.022

  (sin θ/λ)max (Å−1)

0.614

Refinement

 R[F2 > 2σ(F2)], wR(F2), S

0.035, 0.093, 1.07

 No. of reflections

5010

 No. of parameters

318

 H-atom treatment

H-atom parameters constrained

 Δρmax, Δρmin (e Å−3)

0.61, − 0.53